Verzenio is a prescription medicine used in specific breast cancer treatment settings. Understanding its indications can help patients learn why a healthcare professional may consider this medicine as part of a treatment plan. Verzenio is primarily associated with certain hormone receptor positive and HER2 negative breast cancers.
Verzenio, also known by the generic name abemaciclib, is a CDK4 and CDK6 inhibitor. It works by interfering with proteins involved in cell division. Its approved use depends on the characteristics and stage of breast cancer, so treatment decisions should be made by a qualified healthcare professional.
Verzenio is indicated for certain adults with hormone receptor positive and HER2 negative breast cancer. Depending on the clinical situation, it may be used alone or alongside endocrine therapy.
Important treatment contexts include:
The exact indication can depend on factors such as disease stage, tumor characteristics, previous treatment, menopausal status, and other medical considerations.
Before Verzenio is prescribed, healthcare professionals generally review the patient's medical history, current medicines, laboratory results, and overall treatment plan. This helps determine whether the medicine is appropriate and how treatment should be monitored.
Patients should discuss relevant health information with their healthcare professional, including:
Verzenio can cause side effects, including diarrhea, low blood cell counts, nausea, fatigue, decreased appetite, and changes in liver function. More serious reactions can also occur. Patients should follow their prescribed monitoring plan and report concerning symptoms promptly.
Because Verzenio can interact with certain medicines, healthcare professionals may need to review all prescription medicines, over the counter products, and supplements before treatment begins. Patients should not change the dose, stop treatment, or begin another medicine without professional guidance.
Understanding Verzenio indications before use can provide helpful background about where this medicine may fit within breast cancer treatment. However, an indication does not mean the medicine is appropriate for every person with breast cancer. Cancer type, stage, treatment history, medical conditions, and other individual factors all matter. Verzenio should be used only according to a qualified healthcare professional's recommendation and prescribing information. This article is provided for informational purposes only and does not provide medical sales, treatment services, or personalized medical advice.